164 related articles for article (PubMed ID: 24032263)
1. The impact of thrombocytosis on clinicopathological prognostic factors and survival in patients with vulvar cancer.
Uysal A; Gültekin E; Taner CE; Mun S; Yidirim Y
Ginekol Pol; 2013 Jun; 84(6):450-5. PubMed ID: 24032263
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytosis in women with vulvar carcinoma.
Lavie O; Comerci G; Daras V; Bolger BS; Lopes A; Monaghan JM
Gynecol Oncol; 1999 Jan; 72(1):82-6. PubMed ID: 9889035
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
[TBL] [Abstract][Full Text] [Related]
4. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer.
Heng S; Benjapibal M
Asian Pac J Cancer Prev; 2014; 15(23):10231-6. PubMed ID: 25556452
[TBL] [Abstract][Full Text] [Related]
5. Tumor anemia and thrombocytosis in patients with vulvar cancer.
Hefler L; Mayerhofer K; Leibman B; Obermair A; Reinthaller A; Kainz C; Tempfer C
Tumour Biol; 2000; 21(5):309-14. PubMed ID: 10940827
[TBL] [Abstract][Full Text] [Related]
6. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma.
Abu-Zaid A; Alsabban M; Abuzaid M; AlOmar O; Salem H; Al-Badawi IA
Ann Saudi Med; 2017; 37(5):393-400. PubMed ID: 28988254
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer.
Woelber L; Mahner S; Voelker K; Eulenburg CZ; Gieseking F; Choschzick M; Jaenicke F; Schwarz J
Anticancer Res; 2009 Feb; 29(2):545-52. PubMed ID: 19331201
[TBL] [Abstract][Full Text] [Related]
9. Significance of thrombocytosis in clinicopathologic characteristics and prognosis of gastric cancer.
Li FX; Wei LJ; Zhang H; Li SX; Liu JT
Asian Pac J Cancer Prev; 2014; 15(16):6511-7. PubMed ID: 25169479
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review.
Te Grootenhuis NC; Pouwer AW; de Bock GH; Hollema H; Bulten J; van der Zee AGJ; de Hullu JA; Oonk MHM
Gynecol Oncol; 2018 Mar; 148(3):622-631. PubMed ID: 29137809
[TBL] [Abstract][Full Text] [Related]
12. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.
Fonseca-Moutinho JA; Coelho MC; Silva DP
J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688
[TBL] [Abstract][Full Text] [Related]
13. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
Kosary CL
Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
[TBL] [Abstract][Full Text] [Related]
14. An analysis of reported independent prognostic factors for survival in squamous cell carcinoma of the vulva: is tumor size significance being underrated?
Aragona AM; Cuneo NA; Soderini AH; Alcoba EB
Gynecol Oncol; 2014 Mar; 132(3):643-8. PubMed ID: 24418199
[TBL] [Abstract][Full Text] [Related]
15. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S
Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors associated with vulval carcinoma in women aged above and below 65 years.
Heatley MK
J Obstet Gynaecol; 2003 Nov; 23(6):664-5. PubMed ID: 14617475
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva.
Paladini D; Cross P; Lopes A; Monaghan JM
Cancer; 1994 Nov; 74(9):2491-6. PubMed ID: 7923005
[TBL] [Abstract][Full Text] [Related]
18. Characteristic features of recurrences of squamous cell carcinoma of the vulva.
Sznurkowski JJ; Emerich J
Ginekol Pol; 2010 Jan; 81(1):12-9. PubMed ID: 20232693
[TBL] [Abstract][Full Text] [Related]
19. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population.
Gorelick C; Andikyan V; Mack M; Lee YC; Abulafia O
Int J Gynecol Cancer; 2009 Nov; 19(8):1384-9. PubMed ID: 20009894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
